(RTTNews) - Abbott (ABT) said it recorded another quarter of strong growth with an increase in adjusted earnings per share of 22.2 percent year-over-year. Sales were up 14.3 percent on an organic ...

Despite the flood of apocalyptic warnings from COVID-19 testmakers who kicked off 2022 with stark predictions of dwindling diagnostic sales and, therefore, major hits to their year-over-year results, ...

Worldwide Nutrition sales decreased 11.1 percent on a reported basis and 5.7 percent on an organic basis in the fourth quarter. Total worldwide Nutrition and Pediatric Nutrition sales were negatively ...

Abbott Laboratories (NYSE: ABT) has generally been a good investment to hold over the years. Its business is diverse. And the company not only pays a dividend but also has a terrific track record of ...